EA201991443A1 - ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 - Google Patents
ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9Info
- Publication number
- EA201991443A1 EA201991443A1 EA201991443A EA201991443A EA201991443A1 EA 201991443 A1 EA201991443 A1 EA 201991443A1 EA 201991443 A EA201991443 A EA 201991443A EA 201991443 A EA201991443 A EA 201991443A EA 201991443 A1 EA201991443 A1 EA 201991443A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cas protein
- relates
- polypeptide
- cas9 nucleases
- genetic engineering
- Prior art date
Links
- 108091033409 CRISPR Proteins 0.000 title abstract 4
- 101710163270 Nuclease Proteins 0.000 abstract 3
- 238000010353 genetic engineering Methods 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Термостабильные нуклеазы Cas9. Настоящее изобретение относится к области генной инженерии и, в частности, к редактированию нуклеиновых кислот и модификации генома. Настоящее изобретение относится к выделенному белку Cas или его полипептидному фрагменту, имеющему аминокислотную последовательность SEQ ID NO: 1 или последовательность, идентичную ей по меньшей мере на 77%. Белок или полипептид Cas способен к связыванию, расщеплению, маркированию или модификации двухцепочечного полинуклеотида-мишени при температуре в диапазоне от 30 до 100°C включительно. Изобретение также относится к выделенным молекулам нуклеиновой кислоты, кодирующим указанные нуклеазы Cas9, экспрессионным векторам и клеткам-хозяевам. По изобретению также предложены последовательности PAM, узнаваемые белком или полипептидом Cas. Нуклеазы Cas9, раскрытые в настоящем документе, являются новыми инструментами для генетической инженерии при повышенных температурах и имеют особую ценность при генетических манипуляциях с термофильными организмами, в частности микроорганизмами.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2016/081077 WO2018108272A1 (en) | 2016-12-14 | 2016-12-14 | Thermostable cas9 nucleases |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201991443A1 true EA201991443A1 (ru) | 2020-01-14 |
Family
ID=57755254
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991443A EA201991443A1 (ru) | 2016-12-14 | 2016-12-14 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
EA201991442A EA201991442A1 (ru) | 2016-12-14 | 2017-08-16 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
EA201991440A EA201991440A1 (ru) | 2016-12-14 | 2017-08-16 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
EA201991441A EA201991441A1 (ru) | 2016-12-14 | 2017-12-14 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991442A EA201991442A1 (ru) | 2016-12-14 | 2017-08-16 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
EA201991440A EA201991440A1 (ru) | 2016-12-14 | 2017-08-16 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
EA201991441A EA201991441A1 (ru) | 2016-12-14 | 2017-12-14 | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
Country Status (11)
Country | Link |
---|---|
US (5) | US11242513B2 (ru) |
EP (4) | EP3555275A1 (ru) |
JP (6) | JP7182545B2 (ru) |
KR (4) | KR20190104342A (ru) |
CN (4) | CN110312792B (ru) |
AU (4) | AU2016432443B2 (ru) |
BR (4) | BR112019012155A2 (ru) |
CA (4) | CA3046824A1 (ru) |
EA (4) | EA201991443A1 (ru) |
PH (4) | PH12019501344A1 (ru) |
WO (3) | WO2018108272A1 (ru) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2853829C (en) | 2011-07-22 | 2023-09-26 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US20150166982A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting pi3k point mutations |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
WO2016073990A2 (en) | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
CA2986310A1 (en) | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
JP7396783B2 (ja) | 2015-06-09 | 2023-12-12 | エディタス・メディシン、インコーポレイテッド | 移植を改善するためのcrispr/cas関連方法および組成物 |
GB201510296D0 (en) * | 2015-06-12 | 2015-07-29 | Univ Wageningen | Thermostable CAS9 nucleases |
CA2999500A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
EP4269577A3 (en) | 2015-10-23 | 2024-01-17 | President and Fellows of Harvard College | Nucleobase editors and uses thereof |
WO2017165826A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
EP4047092A1 (en) | 2016-04-13 | 2022-08-24 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
SG11201900907YA (en) | 2016-08-03 | 2019-02-27 | Harvard College | Adenosine nucleobase editors and uses thereof |
WO2018031683A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
CN110214180A (zh) | 2016-10-14 | 2019-09-06 | 哈佛大学的校长及成员们 | 核碱基编辑器的aav递送 |
EA201991443A1 (ru) | 2016-12-14 | 2020-01-14 | Вагенинген Университейт | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
EP3592777A1 (en) | 2017-03-10 | 2020-01-15 | President and Fellows of Harvard College | Cytosine to guanine base editor |
CN110914426A (zh) | 2017-03-23 | 2020-03-24 | 哈佛大学的校长及成员们 | 包含核酸可编程dna结合蛋白的核碱基编辑器 |
WO2018201086A1 (en) | 2017-04-28 | 2018-11-01 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
CN110997908A (zh) | 2017-06-09 | 2020-04-10 | 爱迪塔斯医药公司 | 工程化的cas9核酸酶 |
EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE) |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
GB201716590D0 (en) * | 2017-10-10 | 2017-11-22 | Univ Wageningen | Thermostable cas9 nucleases with reduced off-target activity |
JP2021500036A (ja) | 2017-10-16 | 2021-01-07 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | アデノシン塩基編集因子の使用 |
KR102465067B1 (ko) * | 2018-02-15 | 2022-11-10 | 시그마-알드리치 컴퍼니., 엘엘씨 | 진핵 게놈 변형을 위한 조작된 cas9 시스템 |
JP2022505440A (ja) | 2018-11-01 | 2022-01-14 | キージーン ナムローゼ フェンノートシャップ | 植物細胞におけるCRISPR/Casゲノム編集のためのデュアルガイドRNA |
AU2020221274B2 (en) | 2019-02-15 | 2024-02-08 | Sigma-Aldrich Co. Llc. | Crispr/Cas fusion proteins and systems |
BR112021018607A2 (pt) | 2019-03-19 | 2021-11-23 | Massachusetts Inst Technology | Métodos e composições para editar sequências de nucleotídeos |
CN112301018B (zh) * | 2019-05-14 | 2023-07-25 | 深圳华大生命科学研究院 | 新型的Cas蛋白、Crispr-Cas***及其在基因编辑领域中的用途 |
US20220348939A1 (en) * | 2019-07-30 | 2022-11-03 | Hubei University | CRISPR-Cas system for genome editing in Zymomonas mobilis, and applications thereof |
CN110331158B (zh) * | 2019-07-30 | 2021-09-14 | 湖北大学 | 基于运动发酵单胞菌内源CRISPR-Cas***的多基因位点同时编辑方法及其应用 |
WO2021032180A1 (zh) * | 2019-08-21 | 2021-02-25 | 江南大学 | 一种多靶点编辑重组曲霉菌株的可视化筛选方法 |
US11879134B1 (en) * | 2019-09-05 | 2024-01-23 | The Regents Of The University Of Colorado, A Body Corporate | Recombineering machinery to increase homology directed genome editing in thermophilic microbes |
CN116096873A (zh) | 2020-05-08 | 2023-05-09 | 布罗德研究所股份有限公司 | 同时编辑靶标双链核苷酸序列的两条链的方法和组合物 |
CN111778230A (zh) * | 2020-07-17 | 2020-10-16 | 山东舜丰生物科技有限公司 | 一种适用于Cas12蛋白的缓冲***及其应用 |
RU2749307C1 (ru) * | 2020-10-30 | 2021-06-08 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт сельскохозяйственной биотехнологии" (ФГБНУ ВНИИСБ) | Новая компактная нуклеаза CAS9 II типа из Anoxybacillus flavithermus |
CN114480347B (zh) * | 2022-02-21 | 2022-12-23 | 中国科学院地球化学研究所 | 一种纯化Cas12a蛋白的方法 |
CN114934031B (zh) * | 2022-05-25 | 2023-08-01 | 广州瑞风生物科技有限公司 | 新型Cas效应蛋白、基因编辑***及用途 |
JP7152094B1 (ja) | 2022-06-30 | 2022-10-12 | リージョナルフィッシュ株式会社 | tracrRNAユニット、及びゲノム編集方法 |
CN117701530A (zh) * | 2022-12-08 | 2024-03-15 | 广州瑞风生物科技有限公司 | Cas蛋白截短体、构建其的方法及其应用 |
CN116144631B (zh) * | 2023-01-17 | 2023-09-15 | 华中农业大学 | 耐热型核酸内切酶及其介导的基因编辑*** |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2176082B1 (es) | 2000-05-31 | 2004-01-01 | Consejo Superior Investigacion | Bacterias con la capacidad de unir metales pesados y su empleo en la detoxificacion de medios contaminados con metales pesados. |
US7220571B2 (en) | 2000-09-28 | 2007-05-22 | Archer-Daniels-Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
WO2002066622A2 (en) * | 2001-02-23 | 2002-08-29 | Novozymes A/S | Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
US7670807B2 (en) | 2004-03-10 | 2010-03-02 | East Tennessee State Univ. Research Foundation | RNA-dependent DNA polymerase from Geobacillus stearothermophilus |
JP2006230303A (ja) | 2005-02-25 | 2006-09-07 | Art Engineering Kk | 好熱性リパーゼ産生菌およびその利用 |
KR100872695B1 (ko) | 2006-11-27 | 2008-12-10 | 씨제이제일제당 (주) | Gras 미생물로부터 발현된 식품안전형 호열성아라비노스 이성화효소 및 그를 이용한 타가토스의제조방법 |
KR101491867B1 (ko) * | 2007-01-31 | 2015-02-10 | 피페넥스 인크. | 증가된 발현을 위한 박테리아 리더 서열 |
WO2011041402A1 (en) | 2009-09-29 | 2011-04-07 | Butamax(Tm) Advanced Biofuels Llc | Improved flux to acetolactate-derived products in lactic acid bacteria |
MX362866B (es) | 2012-05-25 | 2019-02-20 | Univ California | Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn. |
RS63427B1 (sr) | 2013-03-15 | 2022-08-31 | Cibus Us Llc | Postupci i kompozicije za povećanje efikasnosti modifikacije ciljnog gena korišćenjem genske reparacije posredovane oligonukleotidom |
UA124375C2 (uk) | 2014-03-14 | 2021-09-08 | Кібус Юс Ллс | Спосіб здійснення спрямованої генетичної зміни днк в клітині рослини з використанням нуклеази crispr і модифікованого gron |
US10725041B2 (en) | 2014-11-04 | 2020-07-28 | Versiti Blood Research Institute Foundation, Inc. | Method to bioengineer designer platelets using gene editing and stem cell methodologies |
WO2016073990A2 (en) | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
WO2016099887A1 (en) | 2014-12-17 | 2016-06-23 | E. I. Du Pont De Nemours And Company | Compositions and methods for efficient gene editing in e. coli using guide rna/cas endonuclease systems in combination with circular polynucleotide modification templates |
US20160346359A1 (en) * | 2015-05-01 | 2016-12-01 | Spark Therapeutics, Inc. | Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease |
US20190136248A1 (en) * | 2015-05-15 | 2019-05-09 | Pioneer Hi-Bred International, Inc. | Novel guide rna/cas endonuclease systems |
GB201510296D0 (en) * | 2015-06-12 | 2015-07-29 | Univ Wageningen | Thermostable CAS9 nucleases |
EA201991443A1 (ru) | 2016-12-14 | 2020-01-14 | Вагенинген Университейт | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 |
-
2016
- 2016-12-14 EA EA201991443A patent/EA201991443A1/ru unknown
- 2016-12-14 CN CN201680092098.5A patent/CN110312792B/zh active Active
- 2016-12-14 US US16/469,674 patent/US11242513B2/en active Active
- 2016-12-14 JP JP2019533096A patent/JP7182545B2/ja active Active
- 2016-12-14 EP EP16822931.8A patent/EP3555275A1/en active Pending
- 2016-12-14 WO PCT/EP2016/081077 patent/WO2018108272A1/en unknown
- 2016-12-14 AU AU2016432443A patent/AU2016432443B2/en active Active
- 2016-12-14 CA CA3046824A patent/CA3046824A1/en active Pending
- 2016-12-14 BR BR112019012155-2A patent/BR112019012155A2/pt unknown
- 2016-12-14 KR KR1020197020534A patent/KR20190104342A/ko unknown
-
2017
- 2017-08-16 EA EA201991442A patent/EA201991442A1/ru unknown
- 2017-08-16 KR KR1020197020535A patent/KR102523544B1/ko active IP Right Grant
- 2017-08-16 CN CN201780086541.2A patent/CN110352241B/zh active Active
- 2017-08-16 BR BR112019012165-0A patent/BR112019012165A2/pt unknown
- 2017-08-16 JP JP2019533103A patent/JP7223377B2/ja active Active
- 2017-08-16 KR KR1020197020536A patent/KR102523543B1/ko active IP Right Grant
- 2017-08-16 US US16/469,683 patent/US11976306B2/en active Active
- 2017-08-16 US US16/469,677 patent/US11326162B2/en active Active
- 2017-08-16 AU AU2017377136A patent/AU2017377136B2/en active Active
- 2017-08-16 WO PCT/EP2017/070796 patent/WO2018108338A1/en unknown
- 2017-08-16 EA EA201991440A patent/EA201991440A1/ru unknown
- 2017-08-16 EP EP17757728.5A patent/EP3555276A1/en active Pending
- 2017-08-16 EP EP17761030.0A patent/EP3555277A1/en active Pending
- 2017-08-16 CN CN201780086540.8A patent/CN110382693B/zh active Active
- 2017-08-16 CA CA3046828A patent/CA3046828A1/en active Pending
- 2017-08-16 JP JP2019532936A patent/JP7223376B2/ja active Active
- 2017-08-16 CA CA3046826A patent/CA3046826A1/en active Pending
- 2017-08-16 WO PCT/EP2017/070797 patent/WO2018108339A1/en unknown
- 2017-08-16 AU AU2017377135A patent/AU2017377135B2/en active Active
- 2017-08-16 BR BR112019012173-0A patent/BR112019012173A2/pt unknown
- 2017-12-14 BR BR112019012183-8A patent/BR112019012183A2/pt unknown
- 2017-12-14 EA EA201991441A patent/EA201991441A1/ru unknown
- 2017-12-14 CA CA3046842A patent/CA3046842A1/en active Pending
- 2017-12-14 CN CN201780086546.5A patent/CN110431229B/zh active Active
- 2017-12-14 JP JP2019533098A patent/JP7283698B2/ja active Active
- 2017-12-14 EP EP17829169.6A patent/EP3555278B1/en active Active
- 2017-12-14 US US16/469,691 patent/US20190360002A1/en active Pending
- 2017-12-14 KR KR1020197020537A patent/KR102662270B1/ko active IP Right Grant
- 2017-12-14 AU AU2017377792A patent/AU2017377792B2/en active Active
-
2019
- 2019-06-13 PH PH12019501344A patent/PH12019501344A1/en unknown
- 2019-06-13 PH PH12019501335A patent/PH12019501335A1/en unknown
- 2019-06-13 PH PH12019501346A patent/PH12019501346A1/en unknown
- 2019-06-13 PH PH12019501340A patent/PH12019501340A1/en unknown
-
2022
- 2022-01-14 US US17/575,952 patent/US11939605B2/en active Active
- 2022-07-29 JP JP2022121297A patent/JP2022166045A/ja not_active Withdrawn
- 2022-08-12 JP JP2022128902A patent/JP2022166170A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991442A1 (ru) | ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9 | |
PH12017502281A1 (en) | Thermostable cas9 nucleases | |
CA3166153A1 (en) | Base editors, compositions, and methods for modifying the mitochondrial genome | |
PH12021550904A1 (en) | Novel crispr/cas12f enzyme and system | |
RU2022103603A (ru) | Направляемые нуклеиновыми кислотами нуклеазы | |
JP6902052B2 (ja) | 複数のリガーゼ組成物、システム、および方法 | |
EA201892810A1 (ru) | Гибридные последовательности нуклеиновых кислот для геномной инженерии | |
MX2022005328A (es) | Composiciones y metodos para el reemplazo de alelos con adn codificado por arn. | |
RU2015112583A (ru) | Функциональные локусы fad2 и соответствующие специфичные для сайта-мишени связывающиеся белки, способные индуцировать направленные разрывы | |
CN102757960B (zh) | 一种扩增未知序列的半随机pcr技术及其引物和试剂盒 | |
EA202190454A1 (ru) | Новый crispr-ассоциированный белок и его применение | |
EP4279597A3 (en) | Novel, non-naturally occurring crispr-cas nucleases for genome editing | |
SG11201809242VA (en) | Method for increasing mutation introduction efficiency in genome sequence modification technique, and molecular complex to be used therefor | |
CA3228222A1 (en) | Class ii, type v crispr systems | |
EP3129475B1 (en) | Dna polymerases from the red sea brine pool organisms | |
WO2019204643A3 (en) | Animal pathogen-derived polypeptides and uses thereof for genetic engineering | |
WO2018014799A1 (zh) | 重组酶聚合酶扩增试剂盒、扩增方法及扩增试剂 | |
Li et al. | Clipping of predetermined fragments from the human genome by S1 nuclease–PNA combinations | |
Park et al. | Group II Intron-Like Reverse Transcriptases Function in Double-Strand Break Repair by Microhomology-Mediated End Joining | |
CN107312788A (zh) | 一种tale重复序列载体的构建方法 | |
Ng | Avoiding CRISPR: Plasmid design for genetic engineering | |
Ignatov et al. | Novel small RNAs from Mycobacterium avium | |
Chan | Transcriptome Analysis of Bacterial Response to Heat Shock Using Next‐Generation Sequencing | |
Pandey et al. | A new method for the robust expression and single-step purification of dCas9 for CRISPR interference/activation (CRISPRi/a) applications | |
Selkova et al. | Characterization of Streptococcus uberis Cas9 (SuCas9)-a Type II-A Ortholog Functional in Human Cells |